Xyall raised €6.0M in a Series B round in May 2022. The company is based in Eindhoven, Netherlands. Investors in the round: Brabant Development Agency, Health Investment Partners (HIP), Sioux Technologies. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €6.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.